Patent 7678762 was granted and assigned to Diobex on March, 2010 by the United States Patent and Trademark Office.
Pharmaceutical compositions comprising glucagon can be administered to control and treat diabetes while reducing or eliminating the risk of insulin-induced hypoglycemia. Also provided are methods of administering glucagon so as to reduce the risk of hypoglycemia.